Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41416-020-0980-x http://scihub22266oqcxt.onion/10.1038/s41416-020-0980-x 32641867!7341025!32641867     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Cancer 2020 ; 123 (5): 709-713 Nephropedia Template TP {{tp|p=32641867|t=2020. Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position |pdf=|usr=}}{{32641867}} gab.com Text Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position JO: Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32641867 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic epicentre has moved to the USA and Europe, where it is placing unprecedented demands on healthcare resources and staff availability. These service constraints, coupled with concerns relating to an increased incidence and severity of COVID-19 among patients with cancer, should lead to re-consideration of the risk-benefit balance for standard treatment pathways. This is of particular importance to pancreatic cancer, given that standard diagnostic modalities such as endoscopy may be restricted, and that disease biology precludes significant delays in treatment. In light of this, we sought consensus from UK clinicians with an interest in pancreatic cancer for management approaches that would minimise patient risk and accommodate for healthcare service restrictions. The outcomes are described here and include recommendations for treatment prioritisation, strategies to bridge to later surgical resection in resectable disease and factors that modify the risk-benefit balance for treatment in the resectable through to the metastatic settings. Priority is given to strategies that limit hospital visits, including through the use of hypofractionated precision radiotherapy and chemoradiotherapy treatment approaches. Twit Text FOAVip Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position ????Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32641867 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32641867 #FOAvip English Wikipedia <ref>{{Cite pmid|32641867}}</ref> Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position #MMPMID32641867 Jones CM; Radhakrishna G; Aitken K; Bridgewater J; Corrie P; Eatock M; Goody R; Ghaneh P; Good J; Grose D; Holyoake D; Hunt A; Jamieson NB; Palmer DH; Soonawalla Z; Valle JW; Hawkins MA; Mukherjee S Br J Cancer 2020[Sep]; 123 (5): 709-713 PMID32641867show ga The coronavirus disease 2019 (COVID-19) pandemic epicentre has moved to the USA and Europe, where it is placing unprecedented demands on healthcare resources and staff availability. These service constraints, coupled with concerns relating to an increased incidence and severity of COVID-19 among patients with cancer, should lead to re-consideration of the risk-benefit balance for standard treatment pathways. This is of particular importance to pancreatic cancer, given that standard diagnostic modalities such as endoscopy may be restricted, and that disease biology precludes significant delays in treatment. In light of this, we sought consensus from UK clinicians with an interest in pancreatic cancer for management approaches that would minimise patient risk and accommodate for healthcare service restrictions. The outcomes are described here and include recommendations for treatment prioritisation, strategies to bridge to later surgical resection in resectable disease and factors that modify the risk-benefit balance for treatment in the resectable through to the metastatic settings. Priority is given to strategies that limit hospital visits, including through the use of hypofractionated precision radiotherapy and chemoradiotherapy treatment approaches. |*Betacoronavirus[MESH] |*Consensus[MESH] |*Practice Guidelines as Topic[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology/prevention & control/virology[MESH] |Humans[MESH] |Incidence[MESH] |Pancreatic Neoplasms/*drug therapy/*radiotherapy[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*epidemiology/prevention & control/virology[MESH] |Quarantine/methods[MESH] |Risk[MESH] |SARS-CoV-2[MESH]Considerations for the treatment of pancreatic cancer during the COVID(epmc).pdf DeepDyve Pubget Overpricing